Authors
Latest:
Propelling Medical Innovation Forward in Pharma R&DWith uncertainty surrounding the future of government funding, the onus is being placed on the private sector to continue driving new discoveries.
Latest:
Combating the Opioid Crisis With Long-Acting InjectablesSubstance use disorder is a complex condition that demands innovative solutions, one of which that has shown promise is the use of long-acting injectables.
Latest:
Investing for Success: Finding the Right Launch BalanceChallenge assumptions and reset expectations when it comes to pre-launch SG&A investment to increase the odds of commercial success.
Latest:
China’s Trial Advantage: Tracking Nation’s Growth in Pharma Innovation and Global InvestmentA look at China's emergence as a hub for novel treatment pursuits—and ways international investors can best capitalize on the favorable research trajectory.
Latest:
Clues on Equity Engagement LevelsA survey of 18 biopharmas, measuring their scope and implementation across key health equity dimensions and activities, uncovers useful context as companies seek better alignment of these goals with overall strategy.
Latest:
Data Intermediaries/Software Can Speed the Usage of Real-World DataSurvey taken by pharma and CRO executives evaluates how effectively various programs convert RWD into usable data.
Latest:
The New Era of HCP Engagement: What’s Next on the Path to Digital ExcellenceCompanies now have a unique opportunity to rethink their customer engagement strategy and find new techniques to serve healthcare professionals more effectively.
Latest:
AI-Driven Analytics: From Competitive Advantage to Essential Business ToolMeeting the growing need and demand for fast information to make optimal and timely treatment decisions.
Latest:
Strategic Decision-Making in Early-Stage Drug Development and Lifecycle Management to Maximize a Drug’s Lifetime ValuePresenting a structured, decision-making approach for executive management to make sound strategic decisions for drug development and life cycle management.
Latest:
A Dogged DevotionSaving and transforming as many patients’ lives as possible has been the driving force behind Beth Seidenberg’s audacious career, where she has excelled as a doctor, researcher, and venture capitalist.
Latest:
From Science to Sales: Leveraging Medical Affairs for Commercial TriumphMarketing and sales personnel who leverage the expertise and insights of MedAffairs can often have better success.
Latest:
Partnering to Respond to a Possible Nuclear ThreatRecent explosion at Zaporizhzhia nuclear power plant in Ukraine shows how pharma industry can pull together and take action in the face of adversity.
Latest:
Unlocked Potential — ‘Keying’ in On New-Era EngagementHow adoption of the key account management (KAM) model can help drive pharma’s agility in reaching and influencing a more diverse set of healthcare customers and decision-makers.
Latest:
Patients Are Ready for a Digital Future, Here’s Pharma’s Path Toward the Next Growth HorizonRecent advances from COVID-19 vaccine development put pharma in place to further grow relationship with patients.
Latest:
Navigating the Payer-Health System Nexus: A Strategic Imperative for Biopharma Commercial SuccessThe traditional biopharma approach focused primarily on physician detailing and securing favorable payer contracts, has become inadequate in today’s market.
Latest:
Pharma's ESG Equation: Materiality and Strategy are KeyLife sciences executives who are confronted by too many choices in launching their environmental, social, and governance programs can leverage these two foundational tools to hone in on the set of issues, actions, and disclosures they should prioritize to create value.
Latest:
Project Orbis: Implications for Access and Pricing in the UKPost-Brexit, the UK’s MHRA is looking to join Project Orbis, a global program to speed up patient access to innovative cancer treatments. This article looks at the implications of Project Orbis for commercialization in the UK and the key considerations for industry in considering the project as a pathway.
Latest:
Industry Game Changer: RWE Impacts on Drug DevelopmentCOVID may have given real-world evidence the boost it needed to become routine, especially in areas that demand research innovation and advancement.
Latest:
The Power of Virtual Patient Simulation in CMEVPS access for clinicians is critical in today’s healthcare climate
Latest:
Assessing IDMP MaturityHow pharma firms assess their readiness for IDMP (Identification of Medicinal Products) is important for meeting compliance requirements and ensuring they are prepared for the digital product information management future, writes Adnan Jamil.
Latest:
Is Community the Next Frontier for Cell and Gene Therapy?Both community and academic delivery models play essential and complementary roles in expanding CGT access.
Latest:
Bringing Data to Life: How Tech-Savvy Life Sciences Companies Can Better Serve the Healthcare SectorGoing beyond traditional market segmentation to understand the technological and data analytics capacity of target customers.
Latest:
Mastering Your AI Budget for 2025 SuccessBecause the AI space is changing rapidly, it’s essential that companies are budgeting correctly and using their investments strategically.
